Short answer · Medically reviewed summary · Last updated: 2026-04-07
While the majority of cases are sporadic, approximately 5% to 20% of patients with Pulmonary Fibrosis have a documented family history, indicating a hereditary component known as Familial Pulmonary Fibrosis. Genetic vs. Hereditary Factors It is important to distinguish between "genetic" and "hereditary." Pulmonary Fibrosis is considered a genetic condition because it is often linked to specific variants in genes involved in telomere maintenance (such as TERT or TERC) or surfactant production (such as SFTPC).
Is Pulmonary Fibrosis hereditary?
Is Pulmonary Fibrosis hereditary? The genetic component explained in plain language, reviewed against medical sources, with patient experiences.
While the majority of cases are sporadic, approximately 5% to 20% of patients with Pulmonary Fibrosis have a documented family history, indicating a hereditary component known as Familial Pulmonary Fibrosis.
Genetic vs. Hereditary Factors
It is important to distinguish between "genetic" and "hereditary." Pulmonary Fibrosis is considered a genetic condition because it is often linked to specific variants in genes involved in telomere maintenance (such as TERT or TERC) or surfactant production (such as SFTPC). However, it is not always hereditary; in most cases, the disease arises from a complex interaction between genetic predisposition and environmental triggers, such as smoking or occupational exposure. In familial cases, the inheritance pattern is typically autosomal dominant with incomplete penetrance, meaning an individual may inherit a gene variant but not necessarily develop the disease.
Risk and Genetic Counseling
Because of the variable penetrance, it is difficult to assign a precise percentage risk to children of an affected parent. If a pathogenic variant is identified, each child has a 50% chance of inheriting that specific variant, but not all who inherit it will develop Pulmonary Fibrosis. Genetic testing is typically recommended for individuals with a strong family history or those with early-onset disease. Testing can provide clarity for families, though it does not yet predict the exact age of onset or severity of the condition.
De Novo Mutations and Testing
De novo (spontaneous) mutations are rare in Pulmonary Fibrosis, as the condition is more commonly associated with the inheritance of susceptibility variants that have been passed down through generations. If you are considering family planning, a genetic counselor can help interpret your specific test results and discuss reproductive options, such as preimplantation genetic testing (PGT). Carrier testing is generally reserved for family members once a specific familial variant has been identified by a clinical laboratory.
Medical Disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Pulmonary Fibrosis
- Orphanet: Familial Pulmonary Fibrosis
- OMIM (Online Mendelian Inheritance in Man): Pulmonary Fibrosis, Familial
- Pulmonary Fibrosis Foundation: Genetics and PF
